A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate

Clinical trial NCT00266227 · COMPLETED

Trial details

NCT number: NCT00266227
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2006-01-01
Primary completion: 2007-10-01
Enrollment: 559

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.